Ashland Global Holdings Inc. has appointed two directors to its board as of July 1, 2022: Steve Bishop, former chief executive officer of Procter and Gamble (P&G) consumer health care, and Suzan Harrison, former president of Colgate-Palmolive global oral care.
Steve Bishop is the recently retired chief executive officer of P&G consumer health care. In this capacity, he led the $11 billion consumer health care reportable unit.
Previously, he served in president or group president roles across other P&G global operating units. As a mentor to several executives, he also supported the personal development of women and minorities and enabled broader executive-level diversity in the company. Bishop is a graduate of Purdue University, where he obtained a Bachelor of Science degree in agricultural economics.
Suzan Harrison has held a variety of leadership positions at Colgate-Palmolive Co. She was named president of global oral care in 2011, a position she held until her retirement in 2019.
Previously, she was president of Hill’s Pet Nutrition Inc. North America and held other senior leadership positions, including vice president of marketing for Colgate U.S., and vice president and general manager of Colgate Oral Pharmaceuticals for North America and Europe. Harrison is a member of the board of directors of WestRock Co. and ADM where she chairs the sustainability and social responsibility committee. Harrison holds a Master of Business administration degree from New York University and a Bachelor of Science degree from Binghamton University.
Current members William Dempsey, who has served as a director since 2016, and Ricky Sandler, who joined the board in 2020, have decided not to stand for re-election at Ashland’s Annual Shareholders Meeting in January 2023.
Dempsey is the former executive vice president of global pharmaceuticals at Abbott Laboratories and the current chair of the board’s governance and nominating committee. Dempsey is also a member of the environment, health, safety and quality committee.
Sandler is the founder, and chief executive officer and chief investment officer of Eminence Capital. He is a member of both the audit and governance, and nominating committee.
To allow for an orderly transition, the addition of Bishop and Harrison temporarily increases the size of the board from nine to 11 members until the next annual shareholders meeting in January 2023.
“I am excited to welcome Steve and Suzan as new directors to the Ashland Board, and I am confident they will provide valuable perspectives as we continue to execute our strategy, drive profitability, and enhance value for our shareholders,” said Guillermo Novo, chair and chief executive officer of Ashland.